Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 10 Aug 2026 for Iovance Biotherapeutics, INC..
Filing timeline
BuySaleCorleen M. Roche
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -20.8%Entry US$37.95 · Close at T+365 US$30.07
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Corleen M. Roche: trading record in brief
Filings by Corleen M. Roche span 2 companies, the busiest being Iovance Biotherapeutics, Inc. and CG Oncology, Inc. We count 3 filings; the first trade dates from 29 January 2024 and the latest from 6 August 2026.
Purchases make up the whole of the open-market record (1 purchase, €35k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant and 1 option exercise.
The record was last updated on 10 August 2026 with an option exercise in Iovance Biotherapeutics, Inc. The latest purchase dates back some time: it was published 997 days ago, on 31 January 2024. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Corleen M. Roche
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
49,995 shares0Common StockSEC:0001104659-26-093482:0
21,238 shares@ US$6.210.0027% mcap100.0% of flowCommon StockSEC:0001104659-26-093482:1
2,000 shares@ US$19.00100.0% of flowCommon StockSEC:0000950170-24-009432:0
Canonical exit: 28 Apr 2024 (T+90)
3 of 3 declarations
